Respiratory News and Research

RSS

Noninvasive ventilation and supplemental oxygen during exercise training benefit patients with severe COPD

Researchers from Turkey's Ege University Department of Biostatistics evaluated the effects of noninvasive ventilation (NIV) and supplemental oxygen during exercise training (ET) and found it to have multiple physiologic benefits in patients with severe COPD. Results showed that supplemental oxygen during exercise helped to reduce hyperinflation and improve respiratory muscle function and exercise capacity.

20 Oct 2015

Takeda highlights safety, efficacy of vedolizumab for UC and CD at ACG Annual Scientific Meeting

Takeda Pharmaceuticals, U.S.A., Inc., today announced that data highlighting the efficacy and safety of vedolizumab for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD), will be presented during the 2015 American College of Gastroenterology Annual Scientific Meeting in Honolulu, Hawaii, held on October 16-21.

20 Oct 2015

Luminex's NxTAG Respiratory Pathogen Panel receives CE-IVD marking

Luminex Corporation today announced that it has received CE-IVD marking for its NxTAG Respiratory Pathogen Panel. The Panel detects 21 clinically-relevant viral and bacterial respiratory pathogens, including the atypical bacteria Chlamydophila pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila.

19 Oct 2015

Dehaier secures medical device distribution bid for rural healthcare construction project supported by CDB

Dehaier Medical Systems Ltd., which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced that it has won a medical device distribution bid for a new rural healthcare construction project supported by China Development Bank Corp.

19 Oct 2015

Research reveals that sniffing and gasping could prevent fainting

The current study focused on the most common type of fainting, called vasovagal syncope, which can be caused by prolonged standing or standing up quickly. It leads to drops in blood pressure and heart rate, and a brief loss of consciousness.

19 Oct 2015

Camels in Kenya infected by MERS virus, new study finds

A new study has found that nearly half of camels in parts of Kenya have been infected by the virus that causes Middle East Respiratory Syndrome (MERS) and calls for further research into the role they might play in the transmission of this emerging disease to humans.

19 Oct 2015

Digital health app facilitates early detection, treatment of COPD exacerbation symptoms

A digital health application for reporting symptoms of Chronic Obstructive Pulmonary Disease (COPD) facilitated early detection and treatment of COPD exacerbation symptoms, according to an analysis from the Temple Lung Center published by Telemedicine and eHealth.

19 Oct 2015

Hiroshima University researchers demonstrate how Sendai virus escapes host immune system

A research group at Hiroshima University demonstrated the mechanism by which the Sendai virus (SeV) escapes the host immune system. The researchers examined the crystal structure of the complex of SeV C protein and transcription factor STAT1, and found that SeV C protein inhibits the signal transduction pathway of interferon gamma.

16 Oct 2015

Novel ligand peptide-mimic inhibits abnormal overgrowth of blood vessels, may lead to new anti-cancer drugs

An international research team led by scientists at the University of New Mexico Cancer Center discovered and developed a novel ligand peptide-mimic that inhibits abnormal overgrowth of blood vessels in retinal diseases and tumors. The discovery could lead to new drugs that keep cancers from growing. The team published a paper in the journal Science Translational Medicine.

15 Oct 2015

Quest Diagnostics scientists demonstrate new molecular combing technique that predicts cystic fibrosis, muscular dystrophy

Genetic testing for mutations beyond those currently recommended in medical guidelines may aid the identification of more couples at risk of having a child with cystic fibrosis, according to a study presented today at the 2015 American Society of Human Genetics Annual Meeting, which runs through October 10 in Baltimore, Maryland.

From Quest Diagnostics 13 Oct 2015

Data shows romosozumab better than teriparatide in increasing bone strength in postmenopausal women

Amgen (NASDAQ: AMGN) and UCB (Euronext Brussels: UCB) today presented additional findings from an exploratory sub-study of the previously reported romosozumab Phase 2 trial.

13 Oct 2015

BLS transported patients more likely to survive than ALS transported patients

Patients with trauma, stroke, heart attack and respiratory failure who were transported by basic life support (BLS) ambulances had a better chance of survival than patients who were transported by advanced life support (ALS) ambulances, a study of Medicare patients in urban counties nationwide found.

13 Oct 2015

People often end up in emergency room because of infection-related falls

People who end up in the emergency room because of a fall often are tripped up by an infection, rather than a loose throw rug or poor eyesight, suggests a study being presented at IDWeek 2015.

12 Oct 2015

Antiviral agent protects rhesus monkeys from deadly Ebola virus

Rhesus monkeys were completely protected from the deadly Ebola virus when treated three days after infection with a compound that blocks the virus's ability to replicate. These encouraging preclinical results suggest the compound, known as GS-5734, should be further developed as a potential treatment, according to research findings to be presented tomorrow at the IDWeek conference.

12 Oct 2015

Artificial lung model could provide better understanding of health risks associated with airborne pollution

A life-sized artificial human lung created at the Technion-Israel Institute of Technology is the first diagnostic tool for understanding in real time how tiny particles move and behave in the deepest part of the human lungs (alveolar tissue).

9 Oct 2015

FDA approves Promacta to treat pediatric patients with chronic immune thrombocytopenic purpura

The U.S. Food and Drug Administration today approved Promacta (eltrombopag) to treat low blood platelet count in pediatric patients – ages one year and older – with a rare blood disorder called chronic immune thrombocytopenic purpura (ITP). Promacta can be used in these children when they have not achieved an appropriate response using other ITP medicines or surgery to remove the spleen.

9 Oct 2015

ASA: Epidural or spinal anesthesia preferred for most cesarean deliveries

New research could ease the minds of expectant mothers who may be nervous about epidurals or spinal anesthesia for childbirth. A study of New York state hospitals, published in the Online First edition of Anesthesiology, the official medical journal of the American Society of Anesthesiologists, found the rate of anesthesia-related complications in women who received epidural or spinal anesthesia for cesarean delivery decreased 25 percent over the past decade.

9 Oct 2015

Repatha (evolocumab) injection gets FDA approval for high cholesterol

The U.S. Food and Drug Administration today approved Repatha (evolocumab) injection for some patients who are unable to get their low-density lipoprotein (LDL) cholesterol under control with current treatment options.

9 Oct 2015

Daclizumab HYP superior to interferon in relapsing–remitting MS

The DECIDE study shows that 4-weekly daclizumab high-yield process reduces disease activity in patients with relapsing–remitting multiple sclerosis more effectively than weekly interferon beta-1a, albeit at the cost of more adverse effects.

8 Oct 2015

Clinical study data on Mallinckrodt's H.P. Acthar Gel to be presented at ACR 2015

Mallinckrodt plc, a leading specialty biopharmaceutical company, today announced that data from a pilot study for its H.P. Acthar Gel (repository corticotropin injection) will be presented at the American College of Rheumatology 2015 Annual Meeting to be held November 7-11 in San Francisco.

8 Oct 2015

Respiratory News and Research

Noninvasive ventilation and supplemental oxygen during exercise training benefit patients with severe COPD

Takeda highlights safety, efficacy of vedolizumab for UC and CD at ACG Annual Scientific Meeting

Luminex's NxTAG Respiratory Pathogen Panel receives CE-IVD marking

Dehaier secures medical device distribution bid for rural healthcare construction project supported by CDB

Research reveals that sniffing and gasping could prevent fainting

Camels in Kenya infected by MERS virus, new study finds

Digital health app facilitates early detection, treatment of COPD exacerbation symptoms

Hiroshima University researchers demonstrate how Sendai virus escapes host immune system

Novel ligand peptide-mimic inhibits abnormal overgrowth of blood vessels, may lead to new anti-cancer drugs

Quest Diagnostics scientists demonstrate new molecular combing technique that predicts cystic fibrosis, muscular dystrophy

Data shows romosozumab better than teriparatide in increasing bone strength in postmenopausal women

BLS transported patients more likely to survive than ALS transported patients

People often end up in emergency room because of infection-related falls

Antiviral agent protects rhesus monkeys from deadly Ebola virus

Artificial lung model could provide better understanding of health risks associated with airborne pollution

FDA approves Promacta to treat pediatric patients with chronic immune thrombocytopenic purpura

ASA: Epidural or spinal anesthesia preferred for most cesarean deliveries

Repatha (evolocumab) injection gets FDA approval for high cholesterol

Daclizumab HYP superior to interferon in relapsing–remitting MS

Clinical study data on Mallinckrodt's H.P. Acthar Gel to be presented at ACR 2015

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News